• 1
    Oettlé AG. Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Unio Int Contra Cancrum 1962; 18: 33063.
  • 2
    Templeton AC. Kaposi's sarcoma. In: SommersSC, RosenPP, eds. Pathology annual. New York: Century-Crofts, 1981. 31536.
  • 3
    Hutt MSR. Classical and endemic form of Kaposi's sarcoma. A review. Antibiot Chemother 1984; 32: 127.
  • 4
    Cook-Mozaffari P, Newton R, Beral V, Burkitt DP. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998; 78: 15218.
  • 5
    McHardy J, Williams EH, Geser A, de-Thé G, Beth E, Giraldo G. Endemic Kaposi's sarcoma in the West Nile District of Uganda. Int J Cancer 1984; 33: 20312.
  • 6
    Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW. Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer 1993; 54: 2636.
  • 7
    Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. Br J Cancer 2000; 82: 158592.
  • 8
    Ziegler JL, Newton R, Katongole-Mbidde E, Mbulataiye S, DeCock K, Wabinga H, Mugerwa J, Katabira E, Jaffe H, Parkin DM, Reeves G, Beral V, for the Uganda Kaposi's sarcoma study group. Risk factors for HIV-associated Kaposi's sarcoma in Uganda: a case-control study of 1026 adults. AIDS 1997; 11: 161926.
  • 9
    Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, et al. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus in adults with cancer in Uganda. Int J Cancer 2003; 103: 226232.
  • 10
    Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, Wabinga H, Mbulataiye S, Appleby P, Reeves G, Jaffe H and the Uganda Kaposi's Sarcoma Study Group. A case-control study of Human Immunodeficiency Virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 2001; 92: 6227.
  • 11
    Gao S-J, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler JL, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Med 1996; 2: 9258.
  • 12
    Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, et al. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterising its growth in Nod/SCID mice. Blood 1998; 91: 16719.
  • 13
    Davidovici B, Karakis I, Bouboulia D, Ariad S, Zong J-C, Benharroch D, Dupin N, Weiss R, Hayward G, Sarov B, Boshoff C. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 2001; 93: 194202.
  • 14
    Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Patel M, Ruff P, Bezwoda WR, Hale M, Jentsh U, Retter E, et al. The seroepidemiology of HHV-8/KSHV in a large population of black cancer patients in South Africa. N Engl J Med 1999; 340: 186371.
  • 15
    Dean AD, Dean JA, Burton JH, Dicker RC. Epi Info, version 5: a word processing, database and statistics program for epidemiology on micro-computers. Atlanta, GA: Centers for Disease Control, 1990.
  • 16
    STATA. Stata software. College Park, TX: STATA, 2001.
  • 17
    Ziegler JL. Endemic Kaposi's sarcoma and local volcanic soils. Lancet 1994; 342: 134851.
  • 18
    Maxwell D, Zziwa S. Urban farming in Africa. The case of Kampala. Nairobi: African Center for Technology Studies, 1992.